Suki
PrivateLast Round
Series D
Extension
Jan 30, 2025
Est. Valuation
$500M
Total Funding Raised
$168M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Suki is a healthcare technology company that offers an AI-powered voice assistant designed to streamline administrative tasks and clinical documentation for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Workflow Automation, Vertical SaaS, EHR & EMR
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suki Comparables
Compare Suki with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepScribe | 88% | |
| Ambience Healthcare | 87% | |
| Nabla | 84% |
Suki Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jan 30, 2025 | ||||
| Series D | Oct 10, 2024 | ||||
| Series C | Dec 7, 2021 | ||||
| Series B | Mar 4, 2020 | ||||
| Series A | May 2, 2018 | ||||
Seed | Mar 17, 2017 |
Suki Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series C, Series D, Series B |
| Epsilon Health Investors | Series B |
| Philips Ventures | Series C |
| Gaingels | Series C |
| Inhealth Ventures | Series C, Series D |
| Flare Capital Partners | Series C, Series D, Series B |
| Social Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 31% MoM.
- Mar 1, 2026
New platform enables partners to integrate AI and voice technology.
Recent news
Latest coverage and updates
- hiresSep 10, 2026
Suki hires Jayaraman as MD, MSc, FACS, Medical Director of Clinical Strategy and Research.
- is_developingSep 10, 2026
Suki is developing AI-powered ambient clinical intelligence solutions.
- recognized_asSep 1, 2026
Suki recognized as Transformational Innovation leader in Ambient Clinical Intelligence on Sep 1st '26.
- launchesAug 26, 2026
Suki launched AI dictation tool on Aug 26th '26.
Suki Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Suki's valuation, stock price, and market status.
Is Suki a public or private company?
Suki is a private company.
What is the current stock price of Suki?
Suki is a private company with no public stock price. No recent secondary market data is available.
How much is Suki worth (valuation)?
Suki's valuation is estimated at $500.0M based on funding round data.
Can I buy Suki stock?
Suki shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Suki's last funding round?
Suki's most recent funding round was Series D Extension on October 10, 2024.
Who are the main investors in Suki?
Key investors in Suki include Flare Capital Partners, Social Capital, Hedosophia, Zoom Ventures, March Capital.
Will Suki IPO soon?
No public IPO plans have been announced for Suki.
How can I track Suki secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Suki's secondary market activity and sign up for updates.